• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Updates, 12-11-2025: Press Release

    12-11-2025 | 04:04 pm

    Sun Pharma's GL0034 (utreglutide) demonstrated compelling Phase 1b/2a results for obesity and liver diseases. Studies showed 6.8-8% weight loss, reduced liver fat, and improved cardio-metabolic markers. This GLP-1 asset advances promisingly for future market potential.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited